Body Handbook კატალოგი პროფილი რეიტინგი
მხედველობა BODY HANDBOOK
მხედველობა · §34
Lutein and Zeaxanthin
Two yellow plant pigments, lutein and zeaxanthin, pool at the centre of your retina at roughly a thousand times their level in your blood. They're either arriving from your diet or they aren't. The average Western adult gets one to three milligrams a day; the eye-research target is six to ten. That gap closes for a few dollars a month or a plate of cooked greens, and what closing it buys you depends on your age and your eyes.
გააკეთე · ყოველდღე მტკიცებულება ზომიერი თავი მხედველობა

At the back of the retina they do two jobs: absorb about forty percent of incoming blue light before it hits the light-sensing cells, and mop up free radicals better than vitamin E at that site 1. Of six hundred-odd plant pigments, only these two and a close relative park there 2. The rest is up to your supply.

Supplementing reliably fills the eye. A pooled analysis of twenty trials in nearly two thousand people found a dose-responsive rise in macular pigment, in healthy and diseased eyes alike 3.

Healthy eyes gain a little. A year at the standard dose in young adults sped recovery from bright light and improved fine colour discrimination 4. The lab can measure it; your day won't feel it. The brain claims you'll see aren't made: the largest controlled trial of cognition was null 5.

The real payoff is for the at-risk older eye. Advanced macular degeneration is the leading cause of vision loss in older Western adults: central vision goes and there's no way back. In eyes that already have early disease, adding lutein and zeaxanthin cut progression to the advanced form by about 18% over five years 6, and the signal held at ten 7. Family history, smoking, and decades of a low-greens diet put you on that track.

Two paths, either one works. Diet has the deeper benefit; the pill is more reliable.

Lean pill if you're an older adult at risk, a current or former smoker, or a parent or sibling lost central vision late in life.

Nothing in the first month, which is exactly when most people quit. By three months blood levels are up and the eye is loading 4. By six to twelve months the pigment change shows on testing; the lived version stays subtle, headlights fade a touch faster, the dim menu reads a touch easier. Over years the bet is the slower track: a retina that ages a little better.

The fine print — when to skip it, and what people get wrong

"It prevents macular degeneration." The evidence is for slowing early disease, not stopping it from starting. "It sharpens vision." Small text stays the same; the gains are contrast, glare, and flash recovery 4.

It usually fails for three reasons: quitting at week eight before uptake starts, taking the pill on an empty stomach so half the dose is lost, or buying isolated lutein instead of the 5-to-1 pair that actually accumulates.

Smokers and former smokers must avoid any eye supplement containing beta-carotene; the lutein-zeaxanthin formula is the safe swap, and roughly doubled lung-cancer risk in that group is why 7.

References
  1. 1Bernstein PS, Li B, Vachali PP, et al. (2016). Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Progress in Retinal and Eye Research. link
  2. 2Bone RA, Landrum JT, Friedes LM, et al. (1997). Distribution of lutein and zeaxanthin stereoisomers in the human retina. Experimental Eye Research. link
  3. 3Ma L, Liu R, Du JH, Liu T, Wu SS, Liu XH (2016). Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density. Nutrients. link
  4. 4Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W (2014). A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Investigative Ophthalmology & Visual Science. link
  5. 5Chew EY, Clemons TE, Agrón E, et al. (2015). Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial. JAMA. link
  6. 6Chew EY, Clemons TE, SanGiovanni JP, et al. (2014). Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmology. link
  7. 7Chew EY, Clemons TE, Agrón E, et al. (2022). Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmology. link
  8. 8Eisenhauer B, Natoli S, Liew G, Flood VM (2017). Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection. Nutrients. link
·
34